Gault H, Longerich L, Dawe M, Fine A
Clin Pharmacol Ther. 1984 Jun;35(6):750-4. doi: 10.1038/clpt.1984.106.
Digoxin doses required to maintain therapeutic serum concentrations rose substantially in two patients dependent on dialysis with the commencement of rifampin therapy. When rifampin was discontinued, doses fell to requirements before rifampin. Serum digoxin concentration may fall to ineffective levels with rifampin therapy and rise to potentially toxic levels when rifampin is discontinued.
在两名依赖透析的患者中,随着利福平治疗的开始,维持治疗性血清浓度所需的地高辛剂量大幅增加。当停用利福平后,剂量降至利福平治疗前的需求水平。接受利福平治疗时,血清地高辛浓度可能降至无效水平,而在停用利福平时可能升至潜在毒性水平。